Comportamiento de casos de infección por el nuevo coronavirus SARS-CoV2 que requirieron ingreso hospitalario en una clínica de cuarto nivel
| datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
| dc.contributor.advisor | Cadena Bonfanti, Andrés | |
| dc.contributor.author | Siado Jiménez, Katerine | |
| dc.date.accessioned | 2021-12-03T15:19:06Z | |
| dc.date.available | 2021-12-03T15:19:06Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Introducción: En diciembre de 2019 se describen por primera vez casos de una infección de etiología desconocida que afectaba principalmente el tejido pulmonar en la provincia de Hubei, ciudad de Wuhan, China; detectándose posteriormente una nueva variedad de coronavirus la cual fue denominada síndrome respiratorio agudo severo inducido por coronavirus 2 (SARS-CoV-2) que genera la enfermedad coronavirus 2019. Dada su rápida tasa de transmisión y su aumento en número de casos es declarado como pandemia por la OMS. Objetivo: Caracterizar los aspectos clínicos, epidemiológicos y microbiológicos de los pacientes con infección por SARS-CoV-2 que requirieron ingreso hospitalario en una clínica de cuarto nivel. Metodología: se trata de un estudio observacional descriptivo, cuya información fue obtenida mediante la revisión de historias clínicas de pacientes mayores de edad hospitalizados en sala general o UCI con diagnóstico de COVID-19. | spa |
| dc.description.abstract | Introduction: In December 2019, cases of pneumonia of unknown etiology were described for the first time in Hubei province, Wuhan city, China; subsequently detecting a new variety of coronavirus which was called severe acute respiratory syndrome induced by coronavirus 2 (SARS-CoV-2) that generates the coronavirus disease 2019. Given its rapid transmission rate and its increase in the number of cases, it is declared a pandemic by WHO. Objective: To characterize the clinical, epidemiological, and microbiological aspects of patients with SARS-CoV-2 infection that required hospital admission to a fourth-level clinic. Methodology: it is a descriptive observational study, the information of which was obtained by reviewing the medical records of elderly patients hospitalized in a general ward or ICU with a diagnosis of COVID-19. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/9194 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | SARS-CoV-2 | spa |
| dc.subject | Infección respiratoria | spa |
| dc.subject | Pandemia | spa |
| dc.subject | Respiratory infection | eng |
| dc.subject | Pandemic | eng |
| dc.title | Comportamiento de casos de infección por el nuevo coronavirus SARS-CoV2 que requirieron ingreso hospitalario en una clínica de cuarto nivel | spa |
| dc.type.driver | info:eu-repo/semantics/other | spa |
| dc.type.spa | Otros | spa |
| dcterms.references | Organización Mundial de la Salud. Nuevo coronavirus - China. 2020. | spa |
| dcterms.references | Gorbalenya AE, Baker SC, Baric RS, Groot RJ De, Gulyaeva AA, Haagmans BL, et al. The species and its viruses – a statement of the Coronavirus Study Group. Biorxiv (Cold Spring Harb Lab [Internet]. 2020;1–15. Available from: https://www.biorxiv.org/content/10.1101/2020.02.07.937862v1.full | eng |
| dcterms.references | World Health Organization (WHO). Coronavirus disease 2019 (Covid-19): situation report 52. 2020. | eng |
| dcterms.references | Kowalik MM, Trzonkowski P, Łasińska-Kowara M, Mital A, Smiatacz T, Jaguszewski M. COVID-19 — Toward a comprehensive understanding of the disease. Cardiol J. 2020;27(2):99–114. | eng |
| dcterms.references | Norooznezhad AH, Naja F, Riahi P, Moradinazar M, Shakiba E, Mostafaei S, et al. Primary Symptoms , Comorbidities , and Outcomes of 431 Hospitalized Patients with Con fi rmative RT-PCR Results for COVID-19. Am Soc Trop Med Hyg. 2020;00(0):1–4. | eng |
| dcterms.references | Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061–9. | eng |
| dcterms.references | Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int [Internet]. 2020;97(5):824–8. Available from: https://doi.org/10.1016/j.kint.2020.03.001 | eng |
| dcterms.references | Galluccio F, Ergonenc T, Garcia Martos A, Allam AES, Pérez-Herrero M, Aguilar R, et al. Treatment algorithm for COVID-19: a multidisciplinary point of view. Clin Rheumatol. 2020;39(7):2077–84. | eng |
| dcterms.references | centers of disease control and prevention. People of Any Age with Underlying Medical Conditions. 2020. p. 1. | eng |
| dcterms.references | centers of disease control and prevention. Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19. 2020. p. 1. | eng |
| dcterms.references | Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. Jama [Internet]. 2020;2019:2019–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32203977 | eng |
| dcterms.references | Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. | eng |
| dcterms.references | Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol [Internet]. 2021;19(3):141–54. Available from: http://dx.doi.org/10.1038/s41579-020-00459-7 | eng |
| dcterms.references | Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18(March):20. | eng |
| dcterms.references | Dashraath P, Jing Lin Jeslyn W, Mei Xian Karen L, Li Min L, Sarah L, Biswas A, et al. Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. Am J Obstet Gynecol. 2020 Mar;2019. | eng |
| dcterms.references | Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. N Engl J Med. 2020 Mar;NEJMoa2004500. | eng |
| dcterms.references | Rodríguez-Morales AJ, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P. Going global – Travel and the 2019 novel coronavirus. Travel Med Infect Dis. 2020 Jan;33:101578. | eng |
| dcterms.references | Dunning JW, Merson L, Rohde GGU, Gao Z, Semple MG, Tran D, et al. Open source clinical science for emerging infections. Lancet Infect Dis. 2014;14(1):8–9. | eng |
| dcterms.references | WHO. COVID-19 weekly epidemiological update. World Heal Organ [Internet]. 2021;(58):1–23. Available from: https://www.who.int/publications/m/item/covid-19-weekly-epidemiological-update | eng |
| dcterms.references | Matta S, Chopra KK, Arora VK. Morbidity and mortality trends of Covid 19 in top 10 countries. Indian J Tuberc. 2020;67(4):S167–72. | eng |
| dcterms.references | Monteleone S, Kellici TF, Southey M, Bodkin MJ, Heifetz A. Fighting COVID-19 with Artificial Intelligence. Methods Mol Biol. 2022;(2390):103–12. | eng |
| dcterms.references | Instituto Nacional de salud. Coronavirus en Colombia. 2020. | eng |
| dcterms.references | Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 Mar;(March). | eng |
| dcterms.references | Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19 — Studies Needed. N Engl J Med. 2020 Mar;382(13):1194–6. | eng |
| dcterms.references | Jones DS. History in a Crisis — Lessons for Covid-19. N Engl J Med. 2020 Mar;NEJMp2004361. | eng |
| dcterms.references | World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Update. Who. 2020. | eng |
| dcterms.references | Salud IN de. COVID-19 en Colombia. 2021. | spa |
| dcterms.references | Díaz Pinzón JE. Valoración de la Incidencia del COVID-19 en Colombia para el año 2020. Rev Repert Med y Cirugía. 2021;30:1–9. | spa |
| dcterms.references | Correa-Cuadros JP, Muñoz-Rodríguez MA. SARS-CoV.2/COVID-19 en Colombia: tendencias, predicciones y tensiones sobre el sistema sanitario. Rev Salud Pública. 2020;22(2):1–9. | spa |
| dcterms.references | World Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. 2020. | eng |
| dcterms.references | McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A. 1967;57(4):933–40. | eng |
| dcterms.references | PS M, S P. Coronaviridae. In: In: Fields Virology, 6th ed. 2013. p. 825. | eng |
| dcterms.references | Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–20. | eng |
| dcterms.references | Wilde AH de, Snijder EJ, Kikkert M, Van MJ. Host Factors in Coronavirus Replication. Curr Top Microbiol Immunol [Internet]. 2017;37:35. Available from: http://books.google.com/books?id=_DDwCqx6wpcC&printsec=frontcover&dq=unwritten+rules+of+phd+research&hl=&cd=1&source=gbs_api%255Cnpapers2://publication/uuid/48967E01-55F9-4397-B941-310D9C5405FA%255Cnhttp://medcontent.metapress.com/index/A65RM03P4874243N.pdf%255 | eng |
| dcterms.references | Müller MA, Corman VM, Jores J, Meyer B, Younan M, Liljander A, et al. Mers coronavirus neutralizing antibodies in camels, eastern Africa, 1983–1997. Emerg Infect Dis. 2014;20(12):2093–5. | eng |
| dcterms.references | Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (80- ). 2020;367(6483):1260–3. | eng |
| dcterms.references | Masters PS, Kuo L, Ye R, Hurst KR, Koetzner CA, Hsue B. Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly. Adv Exp Med Biol. 2006;581:163–73. | eng |
| dcterms.references | Kuo L, Masters PS. Genetic Evidence for a Structural Interaction between the Carboxy Termini of the Membrane and Nucleocapsid Proteins of Mouse Hepatitis Virus. J Virol. 2002;76(10):4987–99. | eng |
| dcterms.references | Siu YL, Teoh KT, Lo J, Chan CM, Kien F, Escriou N, et al. The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles. J Virol. 2008;82(22):11318–30. | eng |
| dcterms.references | Yin C. Genotyping coronavirus SARS-CoV-2: methods and implications. 2020;19:1–12. | eng |
| dcterms.references | Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol [Internet]. 2020;5(March). Available from: http://www.ncbi.nlm.nih.gov/pubmed/32123347 | eng |
| dcterms.references | Zhou P, Yang X Lou, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature [Internet]. 2020;579(7798):270–3. Available from: http://dx.doi.org/10.1038/s41586-020-2012-7 | eng |
| dcterms.references | Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet [Internet]. 2020;395(10224):565–74. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30251-8 | eng |
| dcterms.references | Paraskevisa D, Kostakia E, Magiorkinisa G, Panayiotakopoulosb G, Sourvinosc G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020;(January). | eng |
| dcterms.references | Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res [Internet]. 2020;24:91–8. Available from: https://doi.org/10.1016/j.jare.2020.03.005 | eng |
| dcterms.references | Lau SKP, Luk HKH, Wong ACP, Li KSM, Zhu L, He Z, et al. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020;26(7):1542–7. | eng |
| dcterms.references | Doremalen N van, Bushmaker T, Morris DH, Holbrook MG. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;0–2. | eng |
| dcterms.references | Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. Jama. 2020;3–4. | eng |
| dcterms.references | Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad Med J. 2021;97(1147):312–20. | eng |
| dcterms.references | Quirch M, Lee J, Rehman S. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. J Med Internet Res. 2020;22(8):e20193. | eng |
| dcterms.references | Liu Y, Yan L-M, Wan L, Xiang T-X, Le A, Liu J-M, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis [Internet]. 2020;2019(20):2019–20. Available from: https://doi.org/10.1016/S1473-3099(20)30232-2 | eng |
| dcterms.references | Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020;395(10229):1054–62. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30566-3 | eng |
| dcterms.references | Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020;1199–207. | eng |
| dcterms.references | Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy. JAMA - J Am Med Assoc. 2020; | eng |
| dcterms.references | Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc. 2020;2019:3–6. | eng |
| dcterms.references | Cruz MP, Santos E, Cervantes MAV, Juárez ML. COVID-19, a worldwide public health emergency. Rev Clínica Española [Internet]. 2021;221(January):55–61. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254017/pdf/main.pdf | eng |
| dcterms.references | Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo SP, et al. CT Imaging and Differential Diagnosis of COVID-19. Can Assoc Radiol J. 2020;71(2):195–200. | eng |
| dcterms.references | Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. 2020;2(2):e200152. | eng |
| dcterms.references | Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis [Internet]. 2020;20(4):425–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32105637 | eng |
| dcterms.references | Martínez Chamorro E, Díez Tascón A, Ibáñez Sanz L, Ossaba Vélez S, Borruel Nacenta S. Radiologic diagnosis of patients with COVID-19. Radiologia. 2021;63(1):56–73. | eng |
| dcterms.references | Patel A, Jernigan DB. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020. Am J Transplant. 2020;20(3):889–95. | eng |
| dcterms.references | Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections–the state of the art. Emerg Microbes Infect. 2020;9(1):747–56. | eng |
| dcterms.references | Singh B, Datta B, Ashish A, Dutta G. A comprehensive review on current COVID-19 detection methods: From lab care to point of care diagnosis. Sensors Int [Internet]. 2021;2(July):100119. Available from: https://doi.org/10.1016/j.sintl.2021.100119 | eng |
| dcterms.references | Dramé M, Tabue Teguo M, Proye E, Hequet F, Hentzien M, Kanagaratnam L, et al. Should RT-PCR be considered a gold standard in the diagnosis of COVID-19? J Med Virol [Internet]. 2020;92(11):2312–3. Available from: http://dx.doi.org/10.1002/jmv.25996 | eng |
| dcterms.references | World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. | eng |
| dcterms.references | Colson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents [Internet]. 2020;105932. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32145363 | eng |
| dcterms.references | Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents [Internet]. 2020;105949. Available from: https://doi.org/10.1016/j.ijantimicag.2020.105949 | eng |
| dcterms.references | WHO Solidarity Trial Consortium. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results. N Engl J Med. 2021;384(6):497–511. | eng |
| dcterms.references | Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019;53(4). | eng |
| dcterms.references | Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet [Internet]. 2020;395(10223):473–5. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30317-2 | eng |
| dcterms.references | Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, et al. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med. 2020;383(19):1827–37. | eng |
| dcterms.references | Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun [Internet]. 2020;11(1). Available from: http://dx.doi.org/10.1038/s41467-019-13940-6 | eng |
| dcterms.references | Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020;395(10223):507–13. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30211-7 | eng |
| dcterms.references | Chan JFW, Yanfeng Yao A, Yeung M-L, Deng W, Bao L, Lilong, et al. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset. J Infect Dis. 2020;212(12). | eng |
| dcterms.references | Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol [Internet]. 2020;2:0–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32592501 | eng |
| dcterms.references | Sedano-Chiroque FL, Rojas-Miliano C, Vela-Ruiz JM. Perspective on the Primary Prevention of COVID-19. Rev la Fac Med Humana. 2020;20(3):490–7. | eng |
| dcterms.references | Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. Nat Med [Internet]. 2021;27(8):1338–9. Available from: http://dx.doi.org/10.1038/s41591-021-01459-7 | eng |
| dcterms.references | Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;1–10. | eng |
| dcterms.references | Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with different severities: A multicenter study of clinical features. Am J Respir Crit Care Med. 2020;201(11):1380–8. | eng |
| dcterms.references | Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392–8. | eng |
| dcterms.references | Kishaba T, Maeda A, Nabeya D NH. Potential Predictors of Poor Prognosis among Critical COVID-19 Pneumonia Patients Requiring Tracheal Intubation. Tohoku J Exp Med. 2020;252(2):103–7. | eng |
| dcterms.references | Marín-Sánchez A. Características clínicas básicas en los primeros 100 casos fatales de COVID-19 en Colombia. Rev Panam Salud Pública. 2020;44:1. | spa |
| dcterms.references | Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ. 2020;368(January):1–7. | eng |
| dcterms.references | Parag Goyal JJC. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020;382:2372–4. | eng |
| dcterms.references | Colombo C, Albani A, Banfi F, Maltana MA, Meroni L, Villa P, et al. Using vital signs measurements to identify patients with COVID-19 who require early continuous positive airway pressure. Emerg Nurse. 2021; | eng |
| dcterms.references | Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;2600(20):1–7. | eng |
| dcterms.references | Zhao X, Zhang B, Li P, Ma C, Gu J, Hou P, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv. 2020. | eng |
| dcterms.references | Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032–8. | eng |
| dcterms.references | Artero A, Madrazo M, Fernández-Garcés M, Muiño Miguez A, González García A, Crestelo Vieitez A, et al. Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study. J Gen Intern Med. 2021;36(5):1338–45. | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | spa |
| sb.programa | Especialización en Medicina Interna | spa |
| sb.sede | Sede Barranquilla | spa |